Evidence map›Paper›PMID 29982422›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2019

Age Modulates the Association of Caffeine Intake With Cognition and With Gray Matter in Elderly Diabetics.

Rebecca K West, Ramit Ravona-Springer, Abigail Livny, Anthony Heymann, Danit Shahar, Derek Leroith, Rachel Preiss, Ruth Zukran, Jeremy M Silverman, Michal Schnaider-Beeri

Abstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Caffeine in Aging Brains: Cognitive Enhancement, Neurodegeneration, and Emerging Concerns About Addiction.International journal of environmental research and public health · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rebecca K WestDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.
Ramit Ravona-SpringerSheba Medical Center, The Joseph Sagol Neuroscience Center, Tel Aviv University, Tel Aviv, Israel.
Abigail LivnySheba Medical Center, The Joseph Sagol Neuroscience Center, Tel Aviv University, Tel Aviv, Israel.
Anthony HeymannMaccabi Healthcare Services, Tel Aviv, Israel.
Danit ShaharThe S. Daniel Abraham International Center for Health and Nutrition, Department of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Israel.
Derek LeroithDepartment of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Rachel PreissSheba Medical Center, The Joseph Sagol Neuroscience Center, Tel Aviv University, Tel Aviv, Israel.
Ruth ZukranSheba Medical Center, The Joseph Sagol Neuroscience Center, Tel Aviv University, Tel Aviv, Israel.
Jeremy M SilvermanDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.
Michal Schnaider-BeeriDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.

Funding

Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY E. PESSIN · 2015 to 2026
$27.7M
Systemic and dietary advanced glycation end products in type 2 diabetes-related cognitive decline and incident dementia: effects on Alzheimer's pathology and cerebrovascular diseaseR01AG061093 · NIA · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI SCHNAIDER BEERI, MICHAL · 2019 to 2024
$4.3M
Inflammation, long-term diabetes characteristics, and cognitive declineR01AG034087 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SCHNAIDER BEERI, MICHAL · 2009 to 2014
$3.7M
Long term instability of glycemic control and hippocampal functionR21AG043878 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SCHNAIDER BEERI, MICHAL · 2014 to 2015
$375k
NIA NIH HHS R01 AG034087NIA NIH HHS R01 AG061093NIA NIH HHS R21 AG043878NIDDK NIH HHS P30 DK020541
6 · The paper itself

Abstract

backgroundThe association between caffeine and cognitive performance has not been tested in older individuals with type 2 diabetes (T2D). Its association with brain volume in T2D has been tested only in animals.

methodsWe examined the association of caffeine with cognitive function and brain volume in a sample of elderly diabetics participating in the Israel Diabetes and Cognitive Decline Study (n = 638) and the moderating effect of age on this association. In a subsample (n = 185) with magnetic resonance imaging, we also examined these associations with gray and white matter volumes (GM/WM).

resultsUsing linear regression adjusting for cognition-related covariates, we found that higher caffeine intake was associated with better function in overall cognition (p = .018), attention/working memory (p = .002), executive functioning (p = .047), and semantic categorization (p = .026). Interaction analyses of caffeine intake with age were significant for semantic categorization (p = .025), and approached significance for overall cognition (p = .066). This association was driven by the older group (above-median) for whom the association of caffeine intake with semantic categorization (p = .001), attention/working memory (p = .007), executive functioning (p = .005), and overall cognition (p = .002) were significant. In the magnetic resonance imaging subsample, there was an interaction (p = .034) of caffeine intake with age for GM volume; in the older group, higher caffeine intake was associated with greater GM volume (β = .198, p = .033).

conclusionsCaffeine intake may have a beneficial role in cognitive functioning of elderly adults with T2D, which may be moderated by age. Greater GM volume may be a mechanism underlying the association of higher caffeine intake with better cognitive function.

Indexed as

AgedCaffeineCognitionDiabetes Mellitus, Type 2FemaleGray MatterHumansIsraelMagnetic Resonance ImagingMaleOrgan SizeWhite MatterCaffeineAlzheimer’sCognitive agingNeuroimagingType 2 diabetes

Identifiers

PMID29982422
PMCPMC6477644

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.